Original research Bifidobacterium breve LE4 Reduces Alzheimer's Disease Pathology and Confers Neuroprotection by Attenuating Neuroinflammation, Restoring Metabolism, and Preserving Gut Barrier
This study systematically screened 18 Bifidobacterium strains, among which Bifidobacterium breve LE4 exhibited both potent antioxidant activity and lipopolysaccharide (LPS)-reducing capacity, and demonstrated the neuroprotective effects of B. breve LE4.